These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


287 related items for PubMed ID: 36999417

  • 1. A Narrative Review of Emerging Therapies for Hypertrophic Obstructive Cardiomyopathy.
    da Silva Menezes Junior A, de Oliveira ALV, Maia TA, Botelho SM.
    Curr Cardiol Rev; 2023; 19(4):e240323214927. PubMed ID: 36999417
    [Abstract] [Full Text] [Related]

  • 2. Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?
    Poon SS, Field M, Gupta D, Cameron D.
    Interact Cardiovasc Thorac Surg; 2017 Jun 01; 24(6):951-961. PubMed ID: 28329292
    [Abstract] [Full Text] [Related]

  • 3. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ.
    J Am Coll Cardiol; 2007 Jan 23; 49(3):350-7. PubMed ID: 17239717
    [Abstract] [Full Text] [Related]

  • 4. Myectomy versus alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Afanasyev AV, Bogachev-Prokophiev AV, Kashtanov MG, Astapov DA, Zalesov AS, Budagaev SA, Sharifulin RM, Idov EM, Zheleznev SI.
    Interact Cardiovasc Thorac Surg; 2020 Aug 01; 31(2):158-165. PubMed ID: 32386304
    [Abstract] [Full Text] [Related]

  • 5. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery.
    Qin JX, Shiota T, Lever HM, Kapadia SR, Sitges M, Rubin DN, Bauer F, Greenberg NL, Agler DA, Drinko JK, Martin M, Tuzcu EM, Smedira NG, Lytle B, Thomas JD.
    J Am Coll Cardiol; 2001 Dec 01; 38(7):1994-2000. PubMed ID: 11738306
    [Abstract] [Full Text] [Related]

  • 6. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy.
    Smedira NG, Lytle BW, Lever HM, Rajeswaran J, Krishnaswamy G, Kaple RK, Dolney DO, Blackstone EH.
    Ann Thorac Surg; 2008 Jan 01; 85(1):127-33. PubMed ID: 18154797
    [Abstract] [Full Text] [Related]

  • 7. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort.
    Nguyen A, Schaff HV, Hang D, Nishimura RA, Geske JB, Dearani JA, Lahr BD, Ommen SR.
    J Thorac Cardiovasc Surg; 2019 Jan 01; 157(1):306-315.e3. PubMed ID: 30279000
    [Abstract] [Full Text] [Related]

  • 8. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.
    Sedehi D, Finocchiaro G, Tibayan Y, Chi J, Pavlovic A, Kim YM, Tibayan FA, Reitz BA, Robbins RC, Woo J, Ha R, Lee DP, Ashley EA.
    J Cardiol; 2015 Jul 01; 66(1):57-62. PubMed ID: 25238885
    [Abstract] [Full Text] [Related]

  • 9. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
    Shelke AB, Menon R, Kapadiya A, Yalagudri S, Saggu D, Nair S, Narasimhan C.
    Indian Heart J; 2016 Jul 01; 68(5):618-623. PubMed ID: 27773399
    [Abstract] [Full Text] [Related]

  • 10. Extended septal myectomy and left ventricular outflow tract intervention for hypertrophic obstructive cardiomyopathy.
    Pruna-Guillen R, Ascaso M, Affronti A, Quintana E.
    Multimed Man Cardiothorac Surg; 2021 Mar 02; 2021():. PubMed ID: 33691043
    [Abstract] [Full Text] [Related]

  • 11. [Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: the emerging role of the Cardiomyopathy Team].
    Gragnano F, Pasceri V, Limongelli G, Tanzilli G, Calabrò P, Pelliccia F.
    G Ital Cardiol (Rome); 2021 Mar 02; 22(3 Suppl 1):25S-31S. PubMed ID: 33847320
    [Abstract] [Full Text] [Related]

  • 12. The effects of septal myectomy and alcohol septal ablation for hypertrophic cardiomyopathy on the cardiac conduction system.
    Fitzgerald P, Kusumoto F.
    J Interv Card Electrophysiol; 2018 Aug 02; 52(3):403-408. PubMed ID: 30097789
    [Abstract] [Full Text] [Related]

  • 13. Hypertrophic Obstructive Cardiomyopathy: Surgical Myectomy and Septal Ablation.
    Nishimura RA, Seggewiss H, Schaff HV.
    Circ Res; 2017 Sep 15; 121(7):771-783. PubMed ID: 28912182
    [Abstract] [Full Text] [Related]

  • 14. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes.
    Firoozi S, Elliott PM, Sharma S, Murday A, Brecker SJ, Hamid MS, Sachdev B, Thaman R, McKenna WJ.
    Eur Heart J; 2002 Oct 15; 23(20):1617-24. PubMed ID: 12323162
    [Abstract] [Full Text] [Related]

  • 15. Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Transcoronary and Endocardial Approach.
    Aksu T, Guler T, Yalin K, Golcuk SE, Ozcan K.
    Am J Med Sci; 2016 Nov 15; 352(5):466-471. PubMed ID: 27865293
    [Abstract] [Full Text] [Related]

  • 16. Alcohol septal ablation versus surgical septal myectomy of obstructive hypertrophic cardiomyopathy: systematic review and meta-analysis.
    Yokoyama Y, Shimoda T, Shimada YJ, Shimamura J, Akita K, Yasuda R, Takayama H, Kuno T.
    Eur J Cardiothorac Surg; 2023 Mar 01; 63(3):. PubMed ID: 36782361
    [Abstract] [Full Text] [Related]

  • 17. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis.
    Zeng Z, Wang F, Dou X, Zhang S, Pu J.
    Int J Cardiol; 2006 Sep 10; 112(1):80-4. PubMed ID: 16507323
    [Abstract] [Full Text] [Related]

  • 18. Hypertrophic obstructive cardiomyopathy: what, when, why, for whom?
    Mestres CA, Bartel T, Sorgente A, Müller S, Gruner C, Dearani J, Quintana E.
    Eur J Cardiothorac Surg; 2018 Apr 01; 53(4):700-707. PubMed ID: 29438530
    [Abstract] [Full Text] [Related]

  • 19. Predictors of long-term outcome after septal myectomy in symptomatic hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation and residual obstruction.
    Zhu C, Tang B, Cui H, Wang S, Xiao M, Chen Z, Meng Y, Zhao S, Song Y, Yu Q, Wang S.
    J Card Surg; 2019 Jul 01; 34(7):533-540. PubMed ID: 31111576
    [Abstract] [Full Text] [Related]

  • 20. Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy.
    Cui H, Schaff HV, Wang S, Lahr BD, Rowin EJ, Rastegar H, Hu S, Eleid MF, Dearani JA, Kimmelstiel C, Maron BJ, Nishimura RA, Ommen SR, Maron MS.
    J Am Coll Cardiol; 2022 May 03; 79(17):1647-1655. PubMed ID: 35483751
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.